Ratio 125% [RSABE / ABEL]

posted by Helmut Homepage – Vienna, Austria, 2012-05-09 15:05 (4754 d 00:21 ago) – Posting: # 8543
Views: 7,818

Dear drsinghs!

❝ To be more precise I will share a hypothetical case - if 2 waycrossver study is already completed and observed T/R ratio is 115 for Cmax and 125 for AUCt with > 30% intraCV for Cmax and > 45% for AUCt, Can I expect successful results if I go for replicate design?


Setting different regulatory requirements aside (EMA scaling allowed for Cmax only, different statistical models for FDA and EMA) in all regulations the T/R ratio has to be within 80.00–125.00%. If your ratio for AUC in the 2×2 cross-over was already 125% your chance to get a ratio ≤125% is only 50% at any given sample size.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,668 registered users;
101 visitors (0 registered, 101 guests [including 56 identified bots]).
Forum time: 15:27 CEST (Europe/Vienna)

Don’t undertake a project
unless it’s manifestly important
and nearly impossible.    Edwin H. Land

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5